Purpose of Study:

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Study Dates:
November 20, 2022 - January 1, 0001

Type of Study:
Pre-Market

Study Design:
Controlled Design

Study Location:
Nationwide

Lead Institution:
Raleigh-Cary Medical Center

Funding Source:
Bellus Health

Sponsors:

Bellus Health

ClinicalTrails.gov Identifier:
NCT05600777

Sponsor: 
Bellus Health

Contact Email:
[email protected]

Register for Trial
Asthma Educator Institute
, | Jul 11, 2022
Community Connections - RSV: The Illness on Every Parent's Radar This Season
, | Feb 08, 2023